Statins, which inhibit the activity of HMGCR, are the most widely prescribed lipid-regulatory medications for the treatment of dyslipidemia, cardiovascular diseases, chronic kidney disease, and so on. The gene discussed is HMGCR; the disease is chronic kidney disease.